Literature DB >> 18159498

Microscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.

Ada Rs Diehl1, Rodrigo P Dos Santos, Ricardo Zimmerman, Letícia P Luz, Tanara Weiss, Pedro Jacobson, Luciano Z Goldani.   

Abstract

Atypical visceral leishmaniasis is increasingly reported in immunocompromised patients, including patients with AIDS. A case of visceral leishmaniasis in an HIV-infected Brazilian patient with pulmonary and peritoneal involvement is reported. Histological evaluation of pleural fluid and ascites aspirate revealed macrophages with intracellular Leishmania. Polymerase chain reaction analysis was positive for Leishmania in the pleural and ascitic fluid with use of primers specific for Leishmania chagasi. In addition to classical methods for diagnosing leishmaniasis, such as microscopy and culture, polymerase chain reaction detection and identification of Leishmania species in pleural effusions and ascites are important diagnostic tools that should be considered by clinicians evaluating HIV-infected patients from endemic areas of visceral leishmaniasis. The authors review the clinical manifestations, diagnostic and therapeutic aspects of visceral leishmaniasis in immunocompetent and HIV-infected patients.

Entities:  

Keywords:  Diagnosis; HIV; Leishmania; PCR; Polymerase chain reaction; Treatment

Year:  2004        PMID: 18159498      PMCID: PMC2094978          DOI: 10.1155/2004/680153

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  25 in total

Review 1.  Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.

Authors:  H W Murray
Journal:  Int J Infect Dis       Date:  2000       Impact factor: 3.623

Review 2.  HIV-associated visceral leishmaniasis.

Authors:  V Pintado; R López-Vélez
Journal:  Clin Microbiol Infect       Date:  2001-06       Impact factor: 8.067

3.  Maintenance itraconazole for visceral leishmaniasis in HIV infection.

Authors:  A Lafeuillade; P Chaffanjon; E Delbeke; R Quilichini
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

Review 4.  The potential of using recombinant DNA species-specific probes for the identification of tropical Leishmania.

Authors:  D C Barker; L J Gibson; W P Kennedy; A A Nasser; R H Williams
Journal:  Parasitology       Date:  1986       Impact factor: 3.234

5.  Interstitial pneumonitis in human visceral leishmaniasis.

Authors:  M I Duarte; V L da Matta; C E Corbett; M D Laurenti; R Chebabo; H Goto
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jan-Feb       Impact factor: 2.184

6.  Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.

Authors:  V Pintado; P Martín-Rabadán; M L Rivera; S Moreno; E Bouza
Journal:  Medicine (Baltimore)       Date:  2001-01       Impact factor: 1.889

Review 7.  Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.

Authors:  J D Berman
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

8.  Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Authors:  R López-Vélez; F Laguna; J Alvar; J A Pérez-Molina; R Molina; P Martinez; J Villarrubia
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

9.  Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion.

Authors:  C E Chenoweth; S Singal; R D Pearson; R F Betts; D M Markovitz
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

10.  Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.

Authors:  M Mishra; U K Biswas; A M Jha; A B Khan
Journal:  Lancet       Date:  1994-12-10       Impact factor: 79.321

View more
  3 in total

Review 1.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Does Leishmaniasis disease alter the parenchyma and protein expression in salivary glands?

Authors:  Aírton M C Júnior; Fernando A de Amorim Carvalho; Weslany de Oliveira Dantas; Luana C L Gomes; Andrezza B S da Silva; Maria M A de Sousa Cavalcante; Ingrid M de Oliveira; Marina de Deus Moura de Lima; Márcia Dos Santos Rizzo; Carla Maria de Carvalho Leite; Selma Maria Dos Santos Moura; Lúcia de Fátima Almeida de Deus Moura; Benedito B da Silva
Journal:  Exp Biol Med (Maywood)       Date:  2015-11-13

3.  Visceral leishmaniasis with pleural effusion in an immunocompetent patient.

Authors:  Senjuti Dasgupta; Moutushi Saha; Sudipta Chakrabarti; Jayati Chakraborty
Journal:  Lung India       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.